Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Hedysarum alpinum L. polysaccharide extracts are bioactive heteropolysaccharides derived from the roots of the plant Hedysarum alpinum L., a species used in traditional medicine, especially in East Asia[1][4]. These polysaccharide-rich extracts consist mainly of galactose, glucose, xylose, arabinose, and rhamnose, and have demonstrated pharmacological effects including antioxidant, anti-inflammatory, antitumor, anti-aging, and immunomodulatory activities[1][4][5]. Mechanistic studies show that HPS can inhibit the Keap1 signaling and activate the Nrf2 pathway, leading to increased expression of antioxidant enzymes and suppression of oxidative stress. HPS has shown promise in animal models for diabetes (by regulating blood sugar and oxidative damage), liver injury (as an antioxidant and hepatoprotective agent), and other indications such as cardiovascular disease, fibrosis, and neurodegenerative disorders including Alzheimer’s disease[1][2][3][4][5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Hedysarum alpinum L. polysaccharide extracts.